Gene · 4090
Papers3,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| circ_0062582 Promotes Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells in vitro by Elevating SMAD5 Expression through Sponging miR-197-3p. | Cells Tissues Organs | 2025 | 35764065 | PubTator, text mining | PubMed |
| Statement of Retraction: Long non-coding RNA H19 aggravates keloid progression by upregulating SMAD family member 5 expression via miR-196b-5p. | Bioengineered | 2024 | 39651533 | PubTator, text mining | PubMed |
| Exploring Smad5: a review to pave the way for a deeper understanding of the pathobiology of common respiratory diseases. | Mol Med | 2024 | 39578779 | PubTator, text mining | PubMed |
| Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology. | Proc Natl Acad Sci U S A | 2024 | 39541346 | PubTator, text mining | PubMed |
| Extracellular vesicle-functionalized bioactive scaffolds for bone regeneration. | Asian J Pharm Sci | 2024 | 39483718 | PubTator, text mining | PubMed |
| Proteomics-based network pharmacology and molecular docking reveal the potential mechanisms of 5,6,7,4'-tetramethoxyflavone against HeLa cancer cells. | Heliyon | 2024 | 39449708 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs: Emerging insights into therapeutic potential and mechanisms in bone healing. | J Tissue Eng | 2024 | 39371940 | PubTator, text mining | PubMed |
| Combination of bulk RNA and single-cell sequencing unveils PANoptosis-related immunological ecology hallmarks and classification for clinical decision-making in hepatocellular carcinoma. | Sci Rep | 2024 | 39342037 | PubTator, text mining | PubMed |
| miRNAs in Signal Transduction of SMAD Proteins in Breast Cancer. | Int J Mol Sci | 2024 | 39337574 | PubTator, text mining | PubMed |
| Developing fibrin-based biomaterials/scaffolds in tissue engineering. | Bioact Mater | 2024 | 39239261 | PubTator, text mining | PubMed |
| Black phosphorus quantum dot-modified ADSCs as a novel therapeutic for periodontitis bone loss coupling of osteogenesis and osteoimmunomodulation. | Mater Today Bio | 2024 | 38975241 | PubTator, text mining | PubMed |
| Elucidation of how the Mir-23-27-24 cluster regulates development and aging. | Exp Mol Med | 2024 | 38871817 | PubTator, text mining | PubMed |
| Nuclear SMAD5 dances to a different tune in regulating insulin secretion. | Cell Metab | 2024 | 38838638 | PubTator, text mining | PubMed |
| Prediction of the Signaling Pathway in Polycystic Ovary Syndrome Using an Integrated Bioinformatics Approach. | Gynecol Obstet Invest | 2024 | 38810612 | PubTator, text mining | PubMed |
| SEMA3G regulates BMP9 inhibition of VEGF-mediated migration and network formation in pulmonary endothelial cells. | Vascul Pharmacol | 2024 | 38795838 | PubTator, text mining | PubMed |
| Magnetic Graphene Oxide Nanocomposites Boosts Craniomaxillofacial Bone Regeneration by Modulating circAars/miR-128-3p/SMAD5 Signaling Axis. | Int J Nanomedicine | 2024 | 38585472 | PubTator, text mining | PubMed |
| Cytosolic pH is a direct nexus in linking environmental cues with insulin processing and secretion in pancreatic β cells. | Cell Metab | 2024 | 38513648 | PubTator, text mining | PubMed |
| Single-cell profiling and functional screening reveal crucial roles for lncRNAs in the epidermal re-epithelialization of human acute wounds. | Front Surg | 2024 | 38468869 | PubTator, text mining | PubMed |
| The clinical utilization of SNIP1 and its pathophysiological mechanisms in disease. | Heliyon | 2024 | 38304835 | PubTator, text mining | PubMed |
| The scaffold protein AXIN1: gene ontology, signal network, and physiological function. | Cell Commun Signal | 2024 | 38291457 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4090/papers?page=4